Ryder System, Inc.
R News Today: Stay Updated with the Latest Ryder System, Inc. News in Real Time
Find R news now at Meyka AI. Stay informed with the latest Ryder System, Inc. stocks updates, including price news, market analysis, and expert insights.
6597.T stock up 43% to JPY 3000 on JPX close 06 Apr 2026: strong volume may sustain gains
6597.T stock jumps 43% to JPY 3000 on JPX close 06 Apr 2026; volume surge and fundamentals examined
€0.05 intraday low: VisionSys AI (0T8B.F, XETRA) 06 Apr 2026 watch rebound
Intraday update for 0T8B.F stock: €0.05 low, heavy volume; oversold bounce setup and Meyka AI forecast
April 6: USS Gerald R. Ford Fire, Delays Expose US Carrier Bottlenecks
USS Gerald R. Ford fire and maintenance issues spotlight US Navy carrier delays. GAO notes 4 of 11 carriers deployable. What this means for Canadian investors.
Pre-market $452.07: ISRG Intuitive Surgical NASDAQ 06 Apr 2026: AI +29.53%
Pre-market ISRG stock update: price $452.07, PE 57.37, Meyka AI forecast +29.53% annual upside
Artemis II Today April 06: Orion to View Moon’s Bull’s-Eye Terrain
Artemis II targets a rare human-eye view of Mare Orientale on Apr 7 JST. What Orion’s approach means for Japan’s space economy, suppliers, and investors, with risks and watchlists.
Germany Pensions April 6: SPD Push to End MP Perk Puts Reform in Play
Germany pension reform gains momentum as the SPD pension proposal targets MPs, self‑employed, and new civil servants joining statutory pension Germany. Investor impacts ahead.
NGD.TO New Gold (TSX) C$12.16 pre-market Apr 06 2026: heavy volume, watch momentum
NGD.TO stock pre-market at C$12.16 on Apr 06 2026; volume surging, EPS C$1.48, PE 8.22, model forecasts C$20.11
Artemis 2 Live Stream Today, April 6: Orion’s Historic Moon Flyby
Artemis 2 live stream: Australia watches Orion’s historic lunar flyby today, 6 April. What it means for investors, NASA Artemis 2 updates, and the growing space economy.
Aurobindo Pharma Announces Share Buyback at ₹1,475 – Details on Size, Record Date, and More
Aurobindo Pharma has just taken a bold step that grabbed investor attention on April 6, 2026. The Hyderabad‑based pharmaceutical major’s board approved a share buyback at ₹1,475 per share, marking one of the most talked‑about corporate actions in the Indian markets this week. This plan, valued at ₹800 crore, signals confidence from management and offers…